Previous 10 |
WALTHAM, Mass., April 17, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 first quarter financial results before the opening of the market on Thursday, April 25, 2019. The Company will host a conference call at 8:00 a.m...
WALTHAM, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported publication of three new DPNCheck ® clinical studies. DPNCheck is a point-of-care test that provides accurate and cost-effective screening, diagnosis and monitoring of diabetic peripheral ...
LAS VEGAS, Jan. 07, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix Inc. (Nasdaq: NURO) today unveiled its smartest, smallest and most powerful wearable therapeutic to date. With new features seen for the first time at CES, the recently launched Quell ® 2.0 is 50% smaller, yet 20% more p...
NeuroMetrix Inc. ( NURO ) is down by close to 45% since I first wrote about it in August. My sentiment for the company remains largely the same since the time of writing, I believe that this company is truly underappreciated by the market. This article is going to only be about Quell rather th...
NeuroMetrix (NASDAQ: NURO ) announces the U.S. Patent and Trademark Office issued a patent for "novel methods of monitoring electrode-skin contact for safe delivery of electrical stimulation while the user is sleeping." More news on: NeuroMetrix, Inc., Healthcare stocks news, Stocks on the...
WALTHAM, Mass., Dec. 27, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,159,835 titled “Detecting cutaneous electrode peeling using electrode-skin impedance.” The patent cove...
Corbus Pharmaceuticals ( CRBP +5.1% ) and Neurometrix ( NURO +14.9% ) both jump after H.C. Wainwright initiates coverage with Buy ratings and respective $24 and $5 price targets ( I , II ). More news on: Corbus Pharmaceuticals Holdings, Inc., NeuroMetrix, Inc., Healthcare stocks news,...
News, Short Squeeze, Breakout and More Instantly...
WOBURN, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2024. The Company's mission is to reduce the impact of neurological disorders and pain syndromes through innovative non-invasive medica...
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...